Qtr Family Wealth, LLC Biocryst Pharmaceuticals Inc Transaction History
Qtr Family Wealth, LLC
- $133 Billion
- Q1 2025
A detailed history of Qtr Family Wealth, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Qtr Family Wealth, LLC holds 151,555 shares of BCRX stock, worth $1.67 Million. This represents 0.86% of its overall portfolio holdings.
Number of Shares
151,555Holding current value
$1.67 Million% of portfolio
0.86%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
289Shares Held
172MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.7MShares$239 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$220 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$131 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$100 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$89.8 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $2.05B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...